Hjälm-Eriksson M, Ullén A, Johansson H, Levitt S, Nilsson S, Kälkner K-M. Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts. AO [Internet]. 2017 Jan. 2 [cited 2024 Sep. 2];56(1):21-6. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24979